Skip to main content
All lobbying filings

MICHAEL BEST STRATEGIES LLC

Lobbying for SAREPTA THERAPEUTICS · Medical research and drug development company

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$110,000.00
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 4
  • Executive Office of the President (EOP)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

Scientific innovation in healthcare including gene therapy, rare diseases including Duchenne muscular dystrophy

Medical/Disease Research/Clinical Labs

Scientific innovation in healthcare including gene therapy, rare diseases including Duchenne muscular dystrophy

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem